share_log

美银大幅上调诺瓦瓦克斯医药目标价至12美元

Gelonghui Finance ·  May 10 23:11
格隆汇5月11日|美银:将诺瓦瓦克斯医药的目标价从4美元上调至12美元,评级从“跑输大盘”上调至“中性”。
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment